All In MedTech

FDA Clearance Tracker · P170042-S005

Covera™ Vascular Covered Stent

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 7, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 7, 2020

Approved

Time to decision

177 days

Received Apr 13, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P170042-S005
Device name
Covera™ Vascular Covered Stent
Applicant location
Tempe, AZ
Received
Apr 13, 2020
Decided
Oct 7, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P170042

Device type

Device class
Class III

Every decision under product code PFV

FDA's approval statement

As written in FDA's record.

Approval for an update to the labeling to include the 24-month data on patients enrolled in the AVeVA clinical study.

Source documents

Other decisions for C.R. Bard, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.